Clinical prognostic factors in adjuvant melanoma trial
- PMID: 8656271
- DOI: 10.1200/JCO.1996.14.6.1967
Clinical prognostic factors in adjuvant melanoma trial
Comment on
-
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.J Clin Oncol. 1996 Jan;14(1):7-17. doi: 10.1200/JCO.1996.14.1.7. J Clin Oncol. 1996. PMID: 8558223 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
